SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-737198
Filing Date
2016-10-13
Accepted
2016-10-13 08:01:05
Documents
7
Period of Report
2016-10-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d268142d8k.htm 8-K 23908
2 EX-23.1 d268142dex231.htm EX-23.1 1581
3 EX-99.1 d268142dex991.htm EX-99.1 720851
4 EX-99.2 d268142dex992.htm EX-99.2 485524
5 EX-99.3 d268142dex993.htm EX-99.3 575807
6 EX-99.4 d268142dex994.htm EX-99.4 375308
7 GRAPHIC g268142g33o77.jpg GRAPHIC 153103
  Complete submission text file 0001193125-16-737198.txt   2395237
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 161934077
SIC: 2834 Pharmaceutical Preparations